AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Esmos D 30mcg/2.5ml/40mg Capsule SR

Prescription Icon
Prescription Required

Marketer

Apichem Healthcare

Salt Composition

Domperidone (30mcg/2.5ml) + Rabeprazole (40mg)

Overview Esmos D 30mcg/2.5ml/40mg Capsule SR

Gastroesophageal reflux disease (GERD), or acid reflux, can be managed with Esmos D 30mcg/2.5ml/40mg SR capsules, a combination drug. This medication alleviates symptoms like heartburn, abdominal pain, and irritation by neutralizing stomach acid and facilitating gas expulsion for improved comfort. Dosage and duration of Esmos D, taken on an empty stomach, are determined by your physician based on your individual response. Consistent use, as directed, is crucial; premature discontinuation may lead to symptom recurrence and condition exacerbation. Complete disclosure of all other medications to your healthcare provider is essential, as interactions are possible. Common, typically transient, side effects include diarrhea, abdominal discomfort, dry mouth, headache, gas, and fatigue. Report any concerning side effects immediately. Drowsiness and dizziness are potential effects; avoid driving or activities requiring alertness until their impact is known. Alcohol should be avoided due to increased drowsiness risk. Lifestyle adjustments, such as consuming cold milk and abstaining from hot beverages, spicy foods, and chocolate, can enhance treatment effectiveness. Prior to commencing treatment, inform your doctor of any pre-existing kidney or liver conditions, and also disclose pregnancy, pregnancy plans, or breastfeeding.

Primary Ingredients of Esmos D 30mcg/2.5ml/40mg Capsule SR

No text provided. Please provide the text you wish me to rephrase.

Uses of Esmos D 30mcg/2.5ml/40mg Capsule SR

Managing gastroesophageal reflux and peptic ulcers.

Major Benefits of Esmos D 30mcg/2.5ml/40mg Capsule SR:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire capsule without chewing, crushing, or breaking it. Consume the Esmos D 30mcg/2.5ml/40mg sustained-release capsule on an empty stomach.

Common Side effects of Esmos D 30mcg/2.5ml/40mg Capsule SR:

  • Cough
  • Headache
  • Diarrhea
  • Dizziness
  • Inflammation of the nose
  • Abdominal pain
  • Vomiting
  • Weakness
  • Nasal congestion (stuffy nose)
  • Insomnia (difficulty in sleeping)
  • Fundic gland polyps
  • Nausea
  • Constipation
  • Flatulence
  • Back pain
  • Pharyngitis

How to use Esmos D 30mcg/2.5ml/40mg Capsule SR:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the capsule whole; avoid chewing, crushing, or breaking it. Consume Esmos D 30mcg/2.5ml/40mg Capsule SR on an empty stomach.

How Esmos D 30mcg/2.5ml/40mg Capsule SR works:

Esmos D 30mcg/2.5ml/40mg SR capsules contain Domperidone and Rabeprazole, acting synergistically to manage digestive issues. Domperidone, a prokinetic agent, enhances upper gastrointestinal motility, facilitating efficient food passage. Rabeprazole, a proton pump inhibitor (PPI), decreases stomach acid production, providing relief from heartburn and acid indigestion.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when drinking alcohol while taking Esmos D 30mcg/2.5ml/40mg SR capsules. Seek medical advice.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Esmos D 30mcg/2.5ml/40mg SR capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers before recommending its use. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Prolonged-release Esmos D capsules (30 mcg/2.5 ml/40 mg) are likely unsafe for breastfeeding mothers. Available evidence indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingUNSAFE

Taking Esmos D 30mcg/2.5ml/40mg Sustained-Release Capsules might cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Esmos D 30mcg/2.5ml/40mg sustained-release capsules. Dosage modification may be necessary; physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Esmos D 30mcg/2.5ml/40mg Capsule SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. Esmos D 30mcg/2.5ml/40mg Capsule SR is contraindicated for individuals with moderate to severe hepatic dysfunction.

What if you forget to take Esmos D 30mcg/2.5ml/40mg Capsule SR :

Should you forget to take a dose of your Esmos D 30mcg/2.5ml/40mg SR capsule, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Esmos D 30mcg/2.5ml/40mg Capsule SR

LabelValue
Potential for Dependence None.
Type of Medication Gastrointestinal system

FAQs on Esmos D 30mcg/2.5ml/40mg Capsule SR

Esmos D 30mcg/2.5ml/40mg sustained-release capsules contain domperidone and rabeprazole. This medication combination addresses heartburn, acid reflux (GERD—a condition causing stomach acid to rise into the esophagus), and gastric and duodenal ulcers. Domperidone's action on gut motility facilitates smoother food passage through the stomach, thus managing nausea and vomiting.
Patients exhibiting hypersensitivity to rabeprazole, domperidone, or any excipients within Esmos D 30mcg/2.5ml/40mg Capsule SR should avoid its use. Individuals with pre-existing hepatic or renal impairment require careful monitoring when considering this medication.
Indeed, Esmos D 30mcg/2.5ml/40mg SR capsules may induce xerostomia. This side effect is attributed to the domperidone component. To alleviate dry mouth, increase your fluid intake. Keep water readily available overnight. Reduce alcohol consumption and refrain from smoking. If experiencing dry mouth, opt for alcohol-free mouthwash to minimize the potential for dental caries.
Diarrhea is a potential side effect of Esmos D 30mcg/2.5ml/40mg Capsule SR. If diarrhea occurs, increase fluid intake. Refrain from consuming greasy or deep-fried foods while taking this medication. Consult your physician if diarrhea continues or if dehydration symptoms, such as reduced urination and dark, strong-smelling urine, appear.
Store this medication in its original, tightly sealed container or packaging, following all storage guidelines printed on the packaging or label. Discard any leftover medication. Prevent access by children, pets, and other individuals.
Esmos D 30mcg/2.5ml/40mg Capsule SR is generally well-tolerated. Nevertheless, some individuals may experience typical side effects such as diarrhea, abdominal pain, gas, dry mouth, vertigo, and headache, along with less frequent or infrequent adverse reactions. Report any ongoing issues to your physician during treatment.
Optimal administration of Esmos D 30mcg/2.5ml/40mg SR capsules is before the initial meal or while fasting.
Taking Esmos D 30mcg/2.5ml/40mg SR capsules may elevate the likelihood of experiencing an abnormal heart rhythm (severe arrhythmias). While this is a significant potential adverse effect, the probability of occurrence remains quite small. Individuals aged 60 and older might face a marginally increased risk.
Esmos D 30mcg/2.5ml/40mg SR capsules contain Domperidone and Rabeprazole, working together to manage heartburn, acid reflux (GERD), and ulcers affecting the stomach and duodenum. GERD is characterized by stomach acid rising into the esophagus. Domperidone aids in reducing vomiting by promoting efficient movement of food through the digestive tract.
Patients exhibiting hypersensitivity to rabeprazole, domperidone, or any excipient within Esmos D 30mcg/2.5ml/40mg Capsule SR should avoid its use. Individuals with pre-existing hepatic or renal impairment require careful monitoring when considering this medication.
Indeed, Esmos D 30mcg/2.5ml/40mg SR Capsules may induce xerostomia. This side effect is attributed to the domperidone component. To alleviate dry mouth, increase fluid intake. Keep water readily available, especially at night. Reduce alcohol consumption and refrain from smoking. For dry mouth, opt for alcohol-free mouthwash to minimize the potential for dental caries.
Diarrhea is a potential side effect of Esmos D 30mcg/2.5ml/40mg Capsule SR. If diarrhea occurs, increase your fluid intake. Restrict consumption of greasy or deep-fried foods while taking this medicine. Consult your physician if diarrhea continues or you observe dehydration symptoms such as reduced urination and dark, strong-smelling urine.
Esmos D 30mcg/2.5ml/40mg Capsule SR is generally well-tolerated. Nonetheless, some individuals may experience common adverse reactions such as diarrhea, abdominal discomfort, flatulence, dry mouth, vertigo, or cephalgia, along with less frequent or infrequent side effects. Report any ongoing issues to your physician during treatment.
For optimal absorption, Esmos D 30mcg/2.5ml/40mg sustained-release capsules should be administered prior to the initial meal or while fasting.
Taking Esmos D 30mcg/2.5ml/40mg Capsule SR may raise the likelihood of experiencing an abnormal heart rhythm (severe arrhythmias). While this is a significant potential adverse reaction, the probability of it occurring is quite small. However, individuals over sixty might face a marginally elevated risk.
Maintain this medication within its original, tightly sealed container. Follow the storage guidelines provided on the packaging. Discard any remaining medicine. Prevent access by children, pets, and others.
Esmos D 30mcg/2.5ml/40mg ...
114
MRP 139
17% off